January 18, 2023

Study Published on Effectiveness of the Omicron Bivalent Booster

As the SARS-CoV-2 virus continues to mutate over time and new booster vaccines become available, the question arises, are the multivalent boosters more effective at improving immune response than the monovalent vaccines with which we began? This question was addressed by a multi-site group from Columbia University Vagelos College of Physicians and Surgeons (New York) and from the University of Michigan Medical School Department of Pathology.

All News Scientific and Clinical Research
January 13, 2023

The American Board of Pathology Announces the Appointment of May Chan, MD to the Test Development and Advisory Committee for Dermatopathology

The Department of Pathology offers its congratulations to Dr. May Chan, Professor of Dermatopathology, on her appointment to the American Board of Pathology's Test Development and Advisory Committee beginning in 2023. "As an established subject matter expert in dermatopathology, the contributions of Dr. Chan will be highly valued," commented Bonnie Woodworth, ABP Communications Director. Chan, who also serves as the Program Director for the Dermatopathology Fellowship Program, commented, "With this appointment, I’ll be joining seven esteemed dermatopathologists in designing and writing questions for the dermpath board exam and for the dermpath portion of the anatomic pathology board exam.

All News General News
December 22, 2022

Peek Inside a Bank Full of Priceless Gifts

Blood banks need a constant supply of deposits to meet the needs of patients with cancer, traumatic injuries, failing organs, blood diseases, and more. Deep inside the main University of Michigan hospital lies a gleaming new bank, devoted to handling priceless treasure and storing it safely.

All News General News
December 6, 2022

Rogel Researchers Receive $4M Through Prostate Cancer Foundations Inaugural TACTICAL Awards Program

The University of Michigan Rogel Cancer Center researchers received one of the Prostate Cancer Foundation’s four inaugural Class of 2022 TACTICAL (Therapy Acceleration To Intercept Cancer Lethality) Award. This $30 million program will support cross-disciplinary pioneering research toward the goal of developing 21st Century therapies for the most life-threatening form of prostate cancer.

All News General News
Subscribe to All News